ECASS IISchlüsselwörter Ischämischer SchlaganfallThrombolyseKlinische StudieECASS IIIn the USA, recombinant tissue plasminogen activator (rt-PA) has been approved for therapy of acute ischemic stroke (AIS) within a 3 hour time window based on the results of the NINDS [1] trial. Only few ...